Second-quarter 2009 financial results announced by Biosyent

BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today released a summary of its 2009 second quarter financial results.

During the second quarter of 2009 sales increased by 11%, from $236,576 in the second quarter of 2008 to $263,622 in the second quarter of 2009. Total Sales fell by 29% from $524,573 in the first half of 2008 to $370,673 in the first half of 2009. The first half of 2009 was impacted by general recessionary conditions in the economy, higher than normal customer inventories of Protect-It® and prolonged cold weather in the prairie region which is a natural deterrent to stored grain infestation.

Gross Margins decreased from 62.9% in the first half of 2008, to 58.5% in the first half of 2009 primarily due to the selling mix of lower margin products. Management expects that greater sales of higher margin products in the second half will see margins improve to more historic levels.

The net loss for the first half of 2009 was ($232,108) compared to a net loss of ($167,845) in the first half of 2008.

http://www.biosyent.com 

Posted in:

Tags:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.